Adolescent atomoxetine treatment in a rodent model of ADHD: Effects on cocaine self-administration and dopamine transporters in frontostriatal regions

Neuropsychopharmacology

Volumn 38, Issue 13, 2013, Pages 2588-2597

  Somkuwar, Sucharita S ^a   Jordan, Chloe J ^b   Kantak, Kathleen M ^a   Dwoskin, Linda P ^a  

^a University of Kentucky   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

addiction; atomoxetine; attention deficit hyperactivity disorder; cocaine; dopamine transporter; spontaneously hypertensive rat

Indexed keywords

ATOMOXETINE; COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; METHYLPHENIDATE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DRUG DEPENDENCE; MALE; NONHUMAN; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COCAINE; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FRONTAL LOBE; MALE; PROPYLAMINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION;

EID: 84887988471     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.163     Document Type: Article

References (50)

1. Adinoff B, Devous MD Sr, Cooper DB, Best SE, Chandler P, Harris T et al (2003). Resting regional cerebral blood flow and gambling task performance in cocaine-dependent subjects and healthy comparison subjects. Am J Psychiatry 160: 1892-1894.
2. American Academy of Pediatrics Committee on Children With Disabilities and Committee on Drugs (1996). Medication for children with attentional disorders. Pediatrics 98(Part 1): 301-304.
3. Arnsten AF (2009). Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction. CNS Drugs 23(Suppl 1): 33-41.
4. Biederman J, Petty CR, Evans M, Small J, Faraone SV (2010). How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Res 177: 299-304.
5. Bolden-Watson C, Richelson E (1993). Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 52: 1023-1029.
6. Bolla KI, Eldreth DA, London ED, Kiehl KA, Mouratidis M, Contoreggi C et al (2003). Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. NeuroImage 19: 1085-1094.
7. Burgess GC, Depue BE, Ruzic L, Willcutt EG, Du YP, Banich MT (2010). Attentional control activation relates to working memory in attention-deficit/ hyperactivity disorder. Biol Psychiatry 67: 632-640.
8. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH et al (2002). Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharma- cology 27: 699-711.
9. Cubillo A, Halari R, Giampietro V, Taylor E, Rubia K (2011). Fronto-striatal underactivation during interference inhibition and attention allocation in grown up children with attention deficit/hyperactivity disorder and persistent symptoms. Psychiatry Res 193: 17-27.
10. Di Pietro NC, Black YD, Kantak KM (2006). Context-dependent prefrontal cortex regulation of cocaine self-administration and reinstatement behaviors in rats. Eur J Neurosci 24: 3285-3298.
11. Economidou D, Dalley JW, Everitt BJ (2011). Selective norepi-nephrine reuptake inhibition by atomoxetine prevents cue-induced heroin and cocaine seeking. Biol Psychiatry 69: 266-274.
12. Floresco SB, Zhang Y, Enomoto T (2009). Neural circuits subserving behavioral flexibility and their relevance to schizophrenia. Behav Brain Res 204: 396-409.
13. Fusar-Poli P, Rubia K, Rossi G, Sartori G, Balottin U (2012). Striatal dopamine transporter alterations in ADHD: pathophy-siology or adaptation to psychostimulants? A meta-analysis. Am J Psychiatry 169: 264-272.
14. Gamo NJ, Wang M, Arnsten AF (2010). Methylphenidate and atomoxetine enhance prefrontal function through alpha2-adrenergic and dopamine D1 receptors. J Am Acad Child Adolesc Psychiatry 49: 1011-1023.
15. Garnock-Jones KP, Keating GM (2009). Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents. Paediatr Drugs 11: 203-226.
16. Gill KE, Pierre PJ, Daunais J, Bennett AJ, Martelle S, Gage HD et al (2012). Chronic treatment with extended release methylpheni-date does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates. Neuropsychopharmacology 37: 2555-2565.
17. Gulley JM, Doolen S, Zahniser NR (2002). Brief, repeated exposure to substrates down-regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo. J Neurochem 83: 400-411.
18. Harvey RC, Jordan CJ, Tassin DH, Moody KR, Dwoskin LP, Kantak KM (2013). Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatments. Behav Brain Res 244: 38-47.
19. Harvey RC, Sen S, Deaciuc A, Dwoskin LP, Kantak KM (2011). Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function. Neuropsycho-pharmacology 36: 837-847.
20. Heal DJ, Smith SL, Kulkarni RS, Rowley HL (2008). New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD. Pharmacol Biochem Behav 90: 184-197.
21. Janak PH, Bowers MS, Corbit LH (2012). Compound stimulus presentation and the norepinephrine reuptake inhibitor ato-moxetine enhance long-term extinction of cocaine-seeking behavior. Neuropsychopharmacology 37: 975-985.
22. Janak PH, Corbit LH (2011). Deepened extinction following compound stimulus presentation: noradrenergic modulation. Learn Mem 18: 1-10.
23. Jiao X, Pare WP, Tejani-Butt S (2003). Strain differences in the distribution of dopamine transporter sites in rat brain. Progr Neuro-Psychopharmacol Biol Psychiatry 27: 913-919.
24. Kantak KM, Singh T, Kerstetter KA, Dembro KA, Mutebi MM, Harvey RC et al (2008). Advancing the spontaneous hypertensive rat model of attention deficit/hyperactivity disorder. Behav Neurosci 122: 340-357.
25. Kantak KM, Yager LM, Brisotti MF (2013). Impact of medial orbital cortex and medial subthalamic nucleus inactivation, individually and together, on the maintenance of cocaine self-administration behavior in rats. Behav Brain Res 238: 1-9.
26. Lee SS, Humphreys KL, Flory K, Liu R, Glass K (2011). Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev 31: 328-341.
27. Levin FR, Evans SM, Kleber HD (1999). Practical guidelines for the treatment of substance abusers with adult attention-deficit hyperactivity disorder. Psychiatric Serv 50: 1001-1003.
28. Li Q, Lu G, Antonio GE, Mak YT, Rudd JA, Fan M et al (2007). The usefulness of the spontaneously hypertensive rat to model attention-deficit/ hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain. Neurochem Int 50: 848-857.
29. Loh EA, Roberts DC (1990). Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology 101: 262-266.
30. Mannuzza S, Klein RG, Truong NL, Moulton JL 3rd, Roizen ER, Howell KH et al (2008). Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. Am J Psychiatry 165: 604-609.
31. Marusich JA, Darna M, Charnigo RJ, Dwoskin LP, Bardo MT (2011). A multivariate assessment of individual differences in sensation seeking and impulsivity as predictors of amphetamine self-administration and prefrontal dopamine function in rats. Exp Clin Psychopharmacol 19: 275-284.
32. Mash DC, Pablo J, Ouyang Q, Hearn WL, Izenwasser S (2002). Dopamine transport function is elevated in cocaine users. J Neurochem 81: 292-300.
33. Mattiuz EL, Ponsler GD, Barbuch RJ, Wood PG, Mullen JH, Shugert RL et al (2003). Disposition and metabolic fate of atomoxetine hydrochloride: pharmacokinetics, metabolism, and excretion in the Fischer 344 rat and beagle dog. Drug Metab Dispos 31: 88-97.
34. Molina BS, Hinshaw SP, Eugene Arnold L, Swanson JM, Pelham WE, Hechtman L et al (2013). Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry 52: 250-263.
35. Moron JA, Brockington A, Wise RA, Rocha BA, Hope BT (2002). Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci 22(2): 389-395.
36. Pandolfo P, Machado NJ, Kofalvi A, Takahashi RN, Cunha RA (2012). Caffeine regulates frontocorticostriatal dopamine transporter density and improves attention and cognitive deficits in an animal model of attention deficit hyperactivity disorder. Eur Neuropsychopharmacol 23: 317-28.
37. Piazza PV, Deroche-Gamonent V, Rouge-Pont F, Le Moal M (2000). Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposed to addiction. J Neurosci 20: 4226-4232.
38. Richelson E, Pfenning M (1984). Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepi-nephrine uptake. Eur J Pharmacol 104: 277-286.
39. Roessner V, Sagvolden T, Dasbanerjee T, Middleton FA, Faraone SV, Walaas SI et al (2010). Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/ hyperactivity disorder inattentive type. Neuroscience 167: 1183-1191.
40. Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M (2005). Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 57: 1239-1247.
41. Somkuwar SS, Darna M, Kantak KM, Dwoskin LP (2013). Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood. Biochem Pharmacol 86: 309-316.
42. Sun H, Cocker PJ, Zeeb FD, Winstanley CA (2012). Chronic atomoxetine treatment during adolescence decreases impulsive choice, but not impulsive action, in adult rats and alters markers of synaptic plasticity in the orbitofrontal cortex. Psychopharma-cology (Berl) 219: 285-301.
43. Swanson CJ, Perry KW, Koch-Krueger S, Katner J, Svensson KA, Bymaster FP (2006). Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat. Neuropharmacology 50: 755-760.
44. Thanos PK, Michaelides M, Benveniste H, Wang GJ, Volkow ND (2007). Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents. Pharmacol Biochem Behav 87: 426-433.
45. Uylings HB, Groenewegen HJ, Kolb B (2003). Do rats have a prefrontal cortex? Behav Brain Res 146: 3-17.
46. Wilcox CE, Teshiba TM, Merideth F, Ling J, Mayer AR (2011). Enhanced cue reactivity and fronto-striatal functional connectivity in cocaine use disorders. Drug Alcohol Depend 115: 137-144.
47. Wilcox KM, Lindsey KP, Votaw JR, Goodman MM, Martarello L, Carroll FI et al (2002). Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys. Synapse 43: 78-85.
48. Wilens TE, Biederman J, Mick E (1998). Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. Am J Addict/Am Acad Psychiatrists Alcohol Addict 7: 156-163.
49. Wilens TE, Faraone SV, Biederman J, Gunawardene S (2003). Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111: 179-185.
50. Womersley JS, Hsieh JH, Kellaway LA, Gerhardt GA, Russell VA (2011). Maternal separation affects dopamine transporter function in the spontaneously hypertensive rat: an in vivo electrochemical study. Behav Brain Funct 7: 49.